World's Best Scientists 2026 revealed!
Carolyn F. Deacon

Carolyn F. Deacon

D-Index & Metrics

Medicine

D-Index
95
Citations
31526
World Ranking
10107
National Ranking
113

Overview

Carolyn F. Deacon is affiliated with the University of Copenhagen in Denmark and primarily works within the field of Medicine, with a focus on Endocrinology, Diabetes and Metabolism. Their research contributions span across several related subfields including Surgery, Molecular Biology, Oncology, and Cardiology and Cardiovascular Medicine.

Their main areas of study revolve around topics such as:

  • Diabetes Treatment and Management
  • Pancreatic function and diabetes
  • Metabolism, Diabetes, and Cancer
  • Neuropeptides and Animal Physiology
  • Diet and metabolism studies
  • Diabetes Management and Research
  • Peptidase Inhibition and Analysis

Carolyn F. Deacon has contributed to multiple publications in prominent journals, with frequent appearances in venues such as:

  • Diabetes Obesity and Metabolism
  • Frontiers in Endocrinology
  • Nature Reviews Endocrinology
  • Molecular Metabolism
  • JCI Insight

Selected recent papers with corresponding publication years and venues include:

  • Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus, 2020, Nature Reviews Endocrinology
  • What Is an L-Cell and How Do We Study the Secretory Mechanisms of the L-Cell?, 2021, Frontiers in Endocrinology
  • Glucose-dependent insulinotropic polypeptide (GIP), 2025, Molecular Metabolism
  • Antagonizing somatostatin receptor subtype 2 and 5 reduces blood glucose in a gut- and GLP-1R-dependent manner, 2021, JCI Insight
  • Neprilysin Inhibition Increases Glucagon Levels in Humans and Mice With Potential Effects on Amino Acid Metabolism, 2021, Journal of the Endocrine Society

Frequent collaborators in their research include Jens J. Holst, Nicolai J. Wewer Albrechtsen, Sten Madsbad, Christoffer Martinussen, and Kirstine N. Bojsen-Møller. These coauthors appear regularly across publications and contribute collectively to the development of their field of study.

Best Publications

  • Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients

    Tina Vilsbøll;Thure Krarup;Carolyn F. Deacon;Sten Madsbad

  • Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

    Carolyn F Deacon;Michael A Nauck;Maibritt Toft-Nielsen;Lone Pridal

  • Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo

    C F Deacon;A H Johnsen;J J Holst

  • Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

    Lene Hansen;Carolyn F. Deacon;Cathrine Ørskov;Jens J. Holst

  • Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes.

    Jens J. Holst;Carolyn F. Deacon

  • Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes

    Gary A. Herman;Arthur Bergman;Catherine Stevens;Paul Kotey

  • Dipeptidyl peptidase‐4 inhibitors in the treatment of type 2 diabetes: a comparative review

    C. F. Deacon

  • The incretin system and its role in type 2 diabetes mellitus.

    Jens Juul Holst;Tina Vilsbøll;Carolyn F. Deacon

  • Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide.

    Carolyn F. Deacon;Michael A. Nauck;Juris Meier;Katrin Hücking

  • Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

    M. A. Nauck;I. Vardarli;C. F. Deacon;J. J. Holst

  • Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.

    C F Deacon;T E Hughes;J J Holst

  • Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity

    C. F. Deacon;L. B. Knudsen;K. Madsen;F. C. Wiberg

  • Therapeutic strategies based on glucagon-like peptide 1.

    Carolyn F. Deacon

  • Vildagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Model-Assessed β-Cell Function in Patients with Type 2 Diabetes

    A. Mari;W. M. Sallas;Y. L. He;C. Watson

  • Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig.

    C. F. Deacon;L. Pridal;L. Klarskov;M. Olesen

  • The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic mice

    Bidda Rolin;Marianne O. Larsen;Carsten F. Gotfredsen;Carolyn F. Deacon

  • Secretion, Degradation, and Elimination of Glucagon-Like Peptide 1 and Gastric Inhibitory Polypeptide in Patients with Chronic Renal Insufficiency and Healthy Control Subjects

    Juris J. Meier;Michael A. Nauck;Daniel Kranz;Jens J. Holst

  • Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia

    J. J. Meier;B. Gallwitz;N. Siepmann;J. J. Holst

  • Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors

    J. J. Holst;C. F. Deacon

  • Circulation and degradation of GIP and GLP-1.

    C. F. Deacon

Frequent Co-Authors

Jens J. Holst
Jens J. Holst University of Copenhagen
Sten Madsbad
Sten Madsbad University of Copenhagen
Filip K. Knop
Filip K. Knop University of Copenhagen
Juris J. Meier
Juris J. Meier Ruhr University Bochum
Bo Ahrén
Bo Ahrén Lund University
Michael A. Nauck
Michael A. Nauck Ruhr University Bochum
Michael Horowitz
Michael Horowitz University of Adelaide
Mette M. Rosenkilde
Mette M. Rosenkilde University of Copenhagen
Jens F. Rehfeld
Jens F. Rehfeld University of Copenhagen
Matthias Mann
Matthias Mann Max Planck Institute of Biochemistry

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online pathways in medicine and healthcare can offer flexibility and speed up your journey into advanced clinical roles. Many professionals are opting for accelerated programs, such as the shortest dnp programs, which allow nurses to quickly attain the highest level of clinical education. For those who prefer a less research-intensive route, there are dnp programs without dissertation, letting students focus on practical skills rather than lengthy research projects.

Entry into healthcare can also be streamlined with fast track medical programs, designed for those seeking to become Licensed Practical Nurses (LPNs) and start working in a clinical setting sooner. For registered nurses aiming to specialize in mental health, pursuing an advanced role through online psych np programs can open up new career opportunities with flexible study formats.

These online programs cater to diverse career ambitions, reduce time in school, and offer more accessible paths to high-demand roles within the field of medicine.

Best Scientists Citing Carolyn F. Deacon

Trending Scientists